Which two drugs can increase serum digoxin levels and potentially cause toxicity when used concurrently?

Correct answer: Verapamil and diltiazem

Explanation

A key drug interaction to be aware of is the potential for verapamil and diltiazem to inhibit the clearance of digoxin, leading to elevated serum levels and an increased risk of digoxin toxicity. This requires careful monitoring and possible dose adjustments.

Other questions

Question 1

Which of the following calcium channel blockers is specifically identified for use in preventing neurologic damage due to cerebral vasospasm?

Question 2

What is the primary mechanism of action for calcium channel blockers?

Question 3

Which two calcium channel blockers are specifically mentioned to decrease AV nodal conduction in addition to their primary actions?

Question 4

Most calcium channel blockers are contraindicated in decompensated heart failure, except for which two agents?

Question 5

Concurrent use of calcium channel blockers with beta blockers, digoxin, clonidine, and ivabradine may lead to what additive effect?

Question 7

What is a key patient instruction regarding the administration of sustained-release calcium channel blocker capsules?

Question 8

What important patient teaching point is related to dental hygiene for those taking calcium channel blockers?

Question 9

When assessing a patient on long-term verapamil or diltiazem therapy for arrhythmias, what should be monitored continuously during IV therapy and periodically thereafter?

Question 10

What is a major contraindication for the use of most calcium channel blockers, related to heart rhythm and function?

Question 11

What advice should be given to a patient taking calcium channel blockers to minimize orthostatic hypotension?

Question 12

For a patient receiving IV verapamil or diltiazem for arrhythmias, what is a crucial nursing assessment?

Question 13

The effectiveness of calcium channel blockers may be increased by concurrent use with which of the following medications?

Question 14

What is one of the desired outcomes for a patient being treated with a calcium channel blocker for angina?

Question 15

Which of the following is NOT listed as a calcium channel blocker used in the treatment of hypertension?

Question 16

Which factor may enhance the hypotensive effects of calcium channel blockers, requiring a patient to be cautious?

Question 17

Which potential nursing diagnosis is listed as being related to the indications for calcium channel blocker therapy?

Question 18

What is the primary effect of nimodipine on blood vessels?

Question 19

Under the 'Precautions' section, in which patient population should calcium channel blockers be used cautiously?

Question 20

A nurse is assessing a patient taking a calcium channel blocker. Which of the following signs would suggest the development of heart failure (HF)?

Question 21

Besides 2nd- or 3rd-degree heart block, what other condition is listed as a contraindication for calcium channel blockers like verapamil and diltiazem?

Question 22

What should a patient taking calcium channel blockers be advised to do before taking any over-the-counter (OTC) medications?

Question 23

Which of these is NOT an expected therapeutic use of verapamil?

Question 24

How do phenytoin and phenobarbital interact with calcium channel blockers?

Question 25

What assessment should a nurse perform for a patient with angina who is taking a calcium channel blocker?

Question 26

According to the text, what is a primary general action of calcium channel blockers on coronary arteries?

Question 27

What general instruction about medication adherence should be given to patients taking calcium channel blockers?

Question 28

For which reason would a patient taking a calcium channel blocker be advised to carry identification describing their medication regimen?

Question 29

What is the desired outcome related to neurological deficits for a patient treated with a calcium channel blocker for vasospasm?

Question 30

Which statement about the administration of calcium channel blockers with regard to meals is correct?

Question 31

What is a key component of the nursing assessment for a patient on nimodipine for cerebral vasospasm?

Question 32

Among the calcium channel blockers listed, which one is NOT indicated for the treatment and prophylaxis of angina pectoris or coronary artery spasm?

Question 33

A patient asks why they need to inform their surgeon about taking a calcium channel blocker before a procedure. What is the most appropriate reason?

Question 34

Which of the following is NOT a sign of heart failure (HF) that a nurse should routinely assess for in a patient taking a calcium channel blocker?

Question 35

A patient is started on a calcium channel blocker for hypertension. Which outcome indicates the therapy is effective?

Question 36

What is the safety status of calcium channel blockers during pregnancy and lactation according to the text?

Question 37

When is ECG monitoring for arrhythmias specifically recommended for patients on long-term therapy with calcium channel blockers?

Question 38

What is the potential interaction between verapamil/diltiazem and digoxin?

Question 39

Which condition is NOT listed as a general use for calcium channel blockers in the provided text?

Question 40

A patient taking a calcium channel blocker for hypertension should be encouraged to comply with which additional intervention?

Question 41

What is the primary reason for monitoring intake and output ratios and daily weight in a patient taking a calcium channel blocker?

Question 42

What is a key desired outcome for a patient taking a calcium channel blocker for supraventricular tachyarrhythmias?

Question 43

Among the following, which agent is NOT listed as causing additive bradycardia when used with calcium channel blockers?

Question 44

Which patient populations should receive calcium channel blockers with caution, as stated in the 'Precautions' section?

Question 45

A patient with angina is also prescribed concurrent nitrate therapy. What instruction is important for this patient?

Question 46

What potential side effect of calcium channel blockers necessitates the patient teaching point about seeing a dentist frequently for cleanings?

Question 47

What is the consequence of opening, crushing, or chewing sustained-release calcium channel blocker capsules?

Question 48

A patient with a history of decompensated heart failure is prescribed a calcium channel blocker. Which of the following would be an appropriate choice according to the text?

Question 49

What is the rationale for assessing a patient's neurological status when they are taking nimodipine?

Question 50

An increased risk of digoxin toxicity is associated with the concurrent use of digoxin and which two calcium channel blockers?